Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Temporary tracheobronchial stenting in malignant stenoses

C Witt1, S Dinges, B Schmidt

  • 1Department of Internal Medicine I, Medical School (Charité), Humboldt University, Berlin, Germany.

European Journal of Cancer (Oxford, England : 1990)
|February 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Centronuclear myopathy. Histopathological aspects in ten patients with childhood onset.

Arquivos de neuro-psiquiatria·1998
Same author

Purification and biochemical analysis of WprA, a 52-kDa serine protease secreted by B. subtilis as an active complex with its 23-kDa propeptide.

Biochimica et biophysica acta·1998
Same author

A prion protein fragment primes type 1 astrocytes to proliferation signals from microglia.

Neurobiology of disease·1998
Same author

Centronuclear myopathy: clinical aspects of ten Brazilian patients with childhood onset.

Journal of the neurological sciences·1998
Same author

Apamin improves spatial navigation in medial septal-lesioned mice.

European journal of pharmacology·1998
Same author

Congenital melanocytic nevi with placental infiltration by melanocytes: a benign condition that mimics metastatic melanoma.

Archives of dermatology·1998
Same journal

Early-onset colorectal cancer across Europe: Burden, mechanisms, and health-system implications.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Clinical urgency of incidental findings in the first year of the 4-IN-THE-LUNG-RUN lung cancer screening program.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Clinically relevant endpoints and quality-of-life outcomes with darolutamide in patients with metastatic hormone-sensitive prostate cancer: Analyses of the phase III ARASENS trial.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Mapping the anatomical landscape of colorectal tumours: Location-specific efficacy of anti-epidermal growth factor receptor antibodies: Pooled analysis of randomised trials.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Left behind but not left alone: Excluded cell populations in the non-small cell lung cancer stroma predict superior long-term overall survival.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS).

European journal of cancer (Oxford, England : 1990)·2026
See all related articles

Temporary endobronchial stents offer a new strategy for malignant stenosis, improving breathing. Stents can be removed after successful tumor treatment, providing palliation for severe dyspnea when treatment is ineffective.

Area of Science:

  • Pulmonology
  • Oncology
  • Interventional Pulmonology

Background:

  • Malignant stenoses of the airways often cause severe dyspnea.
  • Endobronchial stents are used for palliation of malignant airway obstructions.

Purpose of the Study:

  • To investigate the efficacy of temporary endobronchial stent placement combined with tumor-specific therapy.
  • To assess the feasibility of stent removal after successful tumor reduction.

Main Methods:

  • Prospective study involving 22 patients with severe malignant airway strictures.
  • Implantation of 34 endobronchial stents (various types).
  • Stent placement followed by radiotherapy (18 patients) or chemotherapy (4 patients).

Main Results:

Related Experiment Videos

  • Significant improvement in dyspnea (P < 0.001) and partial oxygen pressure (P < 0.01).
  • Successful stent removal in 50% of cases (11/22) after tumor-specific therapy.
  • Mean interval for stent removal was 31.7 days; mean survival for non-removable stents was 132 days.

Conclusions:

  • Temporary endobronchial stenting is a valuable strategy to bridge the gap until tumor-specific therapy takes effect.
  • Definite stenting is a palliative option for severe dyspnea in bronchial carcinoma when tumor-specific therapy is ineffective.
  • Stent removal is feasible in a significant proportion of patients, improving outcomes.